Inventor · disambiguated record
Yong Xu
Also filed as: XU YONG · XU YONG-JIE
24 granted patents·23 pending applications·187 citations·filing 2004–2025
94Inventor score
Files withSUPERGEN INC6TOLERO PHARMACEUTICALS INC6HUBEI BIO PHARMACEUTICAL INDUSTRIAL TECH INSTITUTE INC5HUMANWELL HEALTHCARE GROUP CO LTD3SUMITOMO DAINIPPON PHARMA ONCOLOGY INC3
Top patents by PatentIndex Score
47 records- 0196US7750007B2Imidazo[1,2-beta]pyridazine and pyrazolo[1,5-alpha]pyrimidine derivatives and their use as protein kinase inhibitorsSUPERGEN INC·Filed 2007·Granted Jul 6, 2010·97 cites·9 claims
- 0295US9394257B2PKM2 modulators and methods for their useTOLERO PHARMACEUTICALS INC·Filed 2013·Granted Jul 19, 2016·22 cites·52 claims
- 0394US7998966B2Axl kinase inhibitorsSUPERGEN INC·Filed 2008·Granted Aug 16, 2011·30 cites·8 claims
- 0492US7939546B2Quinoline derivatives for modulating DNA methylationSUPERGEN INC·Filed 2009·Granted May 10, 2011·14 cites·17 claims
- 0584US10875864B2Substituted imidazo[1,2-B]pyridazines as protein kinase inhibitorsSUMITOMO DAINIPPON PHARMA ONCOLOGY INC·Filed 2019·Granted Dec 29, 2020·1 cites·28 claims
- 0684US10047093B2Substituted imidazo[1,2-B]pyridazines as protein kinase inhibitorsTOLERO PHARMACEUTICALS INC·Filed 2016·Granted Aug 14, 2018·3 cites·42 claims
- 0784US2025129085A1Substituted imidazo[1,2-b]pyridazines as protein kinase inhibitorsSUMITOMO PHARMA AMERICA INC·Filed 2024·Application pending·0 cites
- 0883US10392392B2Substituted imidazo[1,2-B]pyridazines as protein kinase inhibitorsTOLERO PHARMACEUTICALS INC·Filed 2018·Granted Aug 27, 2019·2 cites·35 claims
- 0982US10766865B2PKM2 modulators and methods for their useTOLERO PHARMACEUTICALS INC·Filed 2019·Granted Sep 8, 2020·1 cites·17 claims
- 1082US10472328B2PKM2 modulators and methods for their useTOLERO PHARMACEUTICALS INC·Filed 2018·Granted Nov 12, 2019·2 cites·20 claims
- 1181US9416132B2Substituted imidazo[1,2-b]pyridazines as protein kinase inhibitorsXU YONG·Filed 2012·Granted Aug 16, 2016·3 cites·16 claims
- 1281US8710057B2Imidazo[1,2-B]pyridazine and pyrazolo[1 .5-A]pyrimidine derivatives and their use as protein kinase inhibitorsBEARSS DAVID J·Filed 2011·Granted Apr 29, 2014·5 cites·16 claims
- 1379US10207996B2PKM2 modulators and methods for their useTOLERO PHARMACEUTICALS INC·Filed 2016·Granted Feb 19, 2019·2 cites·37 claims
- 1474US10662174B2BTK inhibitorHUBEI BIO PHARMACEUTICAL INDUSTRIAL TECH INSTITUTE INC·Filed 2017·Granted May 26, 2020·1 cites·8 claims
- 1572US9856262B2Analogues of 4H-pyrazolo[1,5-a] benzimidazole compound as PARP inhibitorsHUBEI BIO-PHARMACEUTICAL INDUSTRIAL TECH INSTITUTE INC·Filed 2015·Granted Jan 2, 2018·2 cites·21 claims
- 1672US2021238183A1Substituted imidazo[1,2-b]pyridazines as protein kinase inhibitorsSUMITOMO DAINIPPON PHARMA ONCOLOGY INC·Filed 2020·Application pending·0 cites
- 1771US2025320217A1Substituted imidazo[1,2-b]pyridazines as protein kinase inhibitorsSUMITOMO PHARMA AMERICA INC·Filed 2025·Application pending·0 cites
- 1871US2021002233A1Pkm2 modulators and methods for their useSUMITOMO DAINIPPON PHARMA ONCOLOGY INC·Filed 2020·Application pending·0 cites
- 1969US10428073B2Salt type and crystal type of 4H-pyrazolo [1, 5-alpha] benzimidazole compound and preparation method and intermediate thereofHUBEI BIO PHARMACEUTICAL INDUSTRIAL TECH INSTITUTE INC·Filed 2016·Granted Oct 1, 2019·1 cites·13 claims
- 2066US10941150B2Salt type and crystal type of 4h-pyrazolo [1, 5-alpha] benzimidazole compound and preparation method and intermediate thereofHUBEI BIO PHARMACEUTICAL INDUSTRIAL TECH INSTITUTE INC·Filed 2019·Granted Mar 9, 2021·0 cites·12 claims
- 2163US10183010B22-oxo-1,2-dihydrobenzo[cd]indole compound and use thereofGUANGZHOU INST BIOMED & HEALTH·Filed 2016·Granted Jan 22, 2019·1 cites·5 claims
- 2263US2013303539A1Compounds with trpv4 activity, compositions and associated methods thereofKRIZAJ DAVID·Filed 2013·Application pending·0 cites
- 2361US2015133411A1Compounds with trpv4 activity, compositions and associated methods thereofUNIV UTAH RES FOUND·Filed 2013·Application pending·0 cites
- 2460US8759384B2Oxo-imidazolyl compoundsBEARSS DAVID J·Filed 2009·Granted Jun 24, 2014·0 cites·8 claims
- 2557US2017065602A1Compounds with trpv4 activity, compositions and associated methods thereofUNIV UTAH RES FOUND·Filed 2016·Application pending·0 cites
- 2656US12331007B2Use of a multidentate phosphite ligand in the catalytic synthesis of adiponitrileZHEJIANG NHU CO LTD·Filed 2022·Granted Jun 17, 2025·0 cites·12 claims
- 2756US2021161837A1Methods for treating cancer with rorgamma inhibitorsUNIV CALIFORNIA·Filed 2020·Application pending·0 cites
- 2855US2025345782A1Method for preparing phosphorus-containing ligandZHEJIANG NHU CO LTD·Filed 2022·Application pending·0 cites
- 2955US2024189266A1Lactoyl Amino Acids for the Treatment of Metabolic DiseaseUNIV LELAND STANFORD JUNIOR·Filed 2022·Application pending·0 cites
- 3054US12297164B2Benzidine compound and application thereofGUANGZHOU IMD THERAPEUTICS CO LTD·Filed 2019·Granted May 13, 2025·0 cites·5 claims
- 3151US2020340007A1Clals protein, its coding gene and use in predicting the herbicide resistance of watermelonBEIJING ACAD AGRIC & FORESTRY·Filed 2020·Application pending·0 cites
- 3250US12435033B2Method and device for preparing adiponitrileZHEJIANG NHU CO LTD·Filed 2020·Granted Oct 7, 2025·0 cites·19 claims
- 3350US2019192454A1Methods for treating cancer with rorgamma inhibitorsUNIV CALIFORNIA·Filed 2018·Application pending·0 cites
- 3449US11999984B2Method and special complex enzyme for hydrolyzing galactomannan (GM) to prepare small-molecule GM and galactomannan oligosaccharide (GMOS)UNIV NANJING FORESTRY·Filed 2021·Granted Jun 4, 2024·0 cites·8 claims
- 3549US2023219925A1Benzo five-membered nitrogen heterocyclic compound and application thereofGUANGZHOU INST BIOMED & HEALTH·Filed 2020·Application pending·0 cites
- 3648US2010227861A1IMIDAZO[1,2-beta]PYRIDAZINE AND PYRAZOLO[1,5-alpha]PYRIMIDINE DERIVATIVES AND THEIR USE AS PROTEIN KINASE INHIBITORSSUPERGEN INC·Filed 2010·Application pending·0 cites
- 3747US10695347B2Pyrimidine derivative and use thereofHUBEI BIO PHARMACEUTICAL INDUSTRIAL TECH INSTITUTE INC·Filed 2016·Granted Jun 30, 2020·0 cites·20 claims
- 3847US2011269772A1Axl kinase inhibitorsSUPERGEN INC·Filed 2011·Application pending·0 cites
- 3945US2022064141A1Benzopyridone heterocyclic compound and use thereofBRIGHTGENE BIO MEDICAL TECH CO LTD·Filed 2020·Application pending·0 cites
- 4044US2011256092A1Quinoline derivatives for modulating dna methylationSUPERGEN INC·Filed 2011·Application pending·0 cites
- 4142US2017112824A1Combination therapies for the treatment of fungal infectionsUNIV WRIGHT STATE·Filed 2016·Application pending·0 cites
- 4240US2016303178A1Pharmaceutical composition, method for preparing the same and use thereofHUMANWELL HEALTHCARE (GROUP) CO LTD·Filed 2014·Application pending·0 cites
- 4340US2017028007A1Solid dispersion containing desmodium styracifolium (osb.) merr. flavonoids, method of preparing same, and use thereofHUMANWELL HEALTHCARE (GROUP) CO LTD·Filed 2014·Application pending·0 cites
- 4439US2007123492A1Analogs of lysophosphatidic acid and methods of making and using thereofPRESTWICH GLENN D·Filed 2004·Application pending·0 cites
- 4538US2012058997A1Imidazo[1,2-b]pyridazine and pyrazolo[1,5-a]pyrimidine derivatives and their use as protein kinase inhibitorsXU YONG·Filed 2011·Application pending·0 cites
- 4632US9724374B2Capsule containing total flavonoids of desmodium styracifolium, method for preparing the same and useHUMANWELL HEALTHCARE (GROUP) CO LTD·Filed 2014·Granted Aug 8, 2017·0 cites·9 claims
- 4730US2010204221A1Pyrrolopyrimidinyl axl kinase inhibitorsVANKAYALAPATI HARIPRASAD·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yong Xu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →